Coronary interventions – Mini focus on out-of-hospital cardiac arrest and cardiogenic shock

Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy

EuroIntervention 2021;16:e1237-e1244. DOI: 10.4244/EIJ-D-20-00139

Pavel Overtchouk
Pavel Overtchouk1,2,3, MD; Olvier Barthélémy2, MD; Marie Hauguel-Moreau2, MD; Paul Guedeney2, MD; Stéphanie Rouanet4, MD; Michel Zeitouni2, MD; Johanne Silvain2, MD; Jean-Philippe Collet2, MD; Eric Vicaut5, MD; Uwe Zeymer6, MD; Steffen Desch7, MD; Holger Thiele7, MD; Gilles Montalescot2, MD
1. Alviss.ai - Read Better, Paris, France; 2. Sorbonne Université, ACTION Study Group, INSERM UMRS_1166, Institut de Cardiologie (AP-HP), Paris, France; 3. Department of Cardiology, University Hospital of Bern, Bern, Switzerland; 4. Statistician Unit, StatEthic, Levallois-Perret, France; 5. ACTION Study Group, Unité de Recherche Clinique, Hôpital Lariboisière (AP-HP), Paris, France; 6. Heart Centre Ludwigshafen, Department of Cardiology, Ludwigshafen, Germany; 7. Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, Leipzig, Germany

Aims: The aim of this study was to determine the prognostic impact of pre- and post-PCI TIMI flow grade and TIMI myocardial perfusion grade (TMPG) in a well-defined group of patients with cardiogenic shock due to acute myocardial infarction.

Methods and results: Patients with infarct-related cardiogenic shock randomised into the CULPRIT-SHOCK trial were included in the angiographic predictor analysis whenever their TIMI flow grade or TMPG was available in the core lab database (96.9% of cases). A multivariable logistic regression analysis, adjusted on non-angiographic covariates, was performed to investigate whether TIMI flow grade or TMPG was independently associated with all-cause mortality or renal replacement therapy up to one year. Pre-PCI TIMI flow grade and TMPG did not impact on mortality. When analysed in separate multivariable models, post-PCI TIMI 3 flow and TMPG grade 3 were both significantly associated with reduced risk of 30-day mortality: aOR 0.61 (95% CI: 0.38-0.97, p=0.037) and 0.46 (95% CI: 0.29-0.72, p<0.001), respectively. When considered in the same multivariable model, only TMPG was significantly associated with 30-day mortality (aOR 0.38 [0.20-0.71], p=0.002), the 30-day composite of all-cause mortality and renal replacement therapy (aOR 0.34 [0.18-0.66], p=0.001) and mortality at one-year follow-up (aOR 0.46 [0.24-0.88], p=0.02).

Conclusions: Post-PCI TIMI flow grade and TMPG are associated with mortality after PCI. TMPG is a better discriminator, supporting microcirculation rather than epicardial reperfusion for prognosis estimation.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

acs/nste-acscardiogenic shockstemi
Coronary interventionsSTEMINSTEMI
Read next article
Cardiovascular mortality and morbidity in patients undergoing percutaneous coronary intervention after out-of-hospital cardiac arrest: a systematic review and meta-analysis

Latest news